Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387253102> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4387253102 abstract "Cardiovascular disease (CVD) is the world’s biggest killer. Current treatments for CVD are failing to deliver on promises to beat this deadly and complex family of diseases. New approaches that go beyond targeting LDL are needed. Cyclarity Therapeutics has developed a novel class of specifically engineered, dimerized cyclodextrin (CD) molecules for the encapsulation of toxic oxidized cholesterol. Oxidized cholesterol accumulates over time and causes dysfunction in many cell types, linking it to several age-related diseases including atherosclerosis. Presently, treatments for atherosclerosis are invasive, expensive, and/or show limited benefits. Here, a combination of in silico, in vitro, and ex vivo methods are used to implement a synergistic rational drug design strategy for developing CDs to remove atherogenic oxidized cholesterol (primarily 7-ketocholesterol (7KC)) from cells and tissues. Our results thus far indicate that our lead compound, UDP-003, can both prevent and reverse the formation of atherogenic foam cells in-vitro. UDP-003 binds and clears 7KC from in-vivo and ex-vivo systems selectivity. IND enabling studies, including pivotal GLP studies in rodent and non-rodent species, are complete and show that UDP-003 has an excellent safety profile with no significant clinical liabilities. UDP-003 has been awarded the Innovative Licensing and Access Pathway (ILAP) Innovation Passport by the MHRA, which is accelerating Cyclarity’s path to clinic and will facilitate rapid and innovative clinical trials. In totality, our data suggest that targeted removal of 7KC from foam cells with our proprietary class of cyclodextrin compounds has the potential to prevent and reverse the formation of atherosclerotic plaques. This innovation represents the first disease-modifying therapeutic approach to treating atherosclerotic disease." @default.
- W4387253102 created "2023-10-03" @default.
- W4387253102 creator A5002865865 @default.
- W4387253102 creator A5009658309 @default.
- W4387253102 creator A5010686969 @default.
- W4387253102 creator A5021488616 @default.
- W4387253102 creator A5033369981 @default.
- W4387253102 creator A5040003374 @default.
- W4387253102 creator A5041705455 @default.
- W4387253102 creator A5046470781 @default.
- W4387253102 creator A5064618853 @default.
- W4387253102 creator A5084581926 @default.
- W4387253102 creator A5092985512 @default.
- W4387253102 creator A5092985513 @default.
- W4387253102 date "2023-05-01" @default.
- W4387253102 modified "2023-10-03" @default.
- W4387253102 title "Abstract 710: Specific Removal Of Oxidized Cholesterol With A Cyclodextrin Dimer Drug Candidate Towards Reversing Atherosclerosis" @default.
- W4387253102 doi "https://doi.org/10.1161/atvb.43.suppl_1.710" @default.
- W4387253102 hasPublicationYear "2023" @default.
- W4387253102 type Work @default.
- W4387253102 citedByCount "0" @default.
- W4387253102 crossrefType "journal-article" @default.
- W4387253102 hasAuthorship W4387253102A5002865865 @default.
- W4387253102 hasAuthorship W4387253102A5009658309 @default.
- W4387253102 hasAuthorship W4387253102A5010686969 @default.
- W4387253102 hasAuthorship W4387253102A5021488616 @default.
- W4387253102 hasAuthorship W4387253102A5033369981 @default.
- W4387253102 hasAuthorship W4387253102A5040003374 @default.
- W4387253102 hasAuthorship W4387253102A5041705455 @default.
- W4387253102 hasAuthorship W4387253102A5046470781 @default.
- W4387253102 hasAuthorship W4387253102A5064618853 @default.
- W4387253102 hasAuthorship W4387253102A5084581926 @default.
- W4387253102 hasAuthorship W4387253102A5092985512 @default.
- W4387253102 hasAuthorship W4387253102A5092985513 @default.
- W4387253102 hasConcept C104317684 @default.
- W4387253102 hasConcept C150903083 @default.
- W4387253102 hasConcept C185592680 @default.
- W4387253102 hasConcept C202751555 @default.
- W4387253102 hasConcept C207001950 @default.
- W4387253102 hasConcept C26291073 @default.
- W4387253102 hasConcept C2775905019 @default.
- W4387253102 hasConcept C2778163477 @default.
- W4387253102 hasConcept C2779433975 @default.
- W4387253102 hasConcept C2780035454 @default.
- W4387253102 hasConcept C55493867 @default.
- W4387253102 hasConcept C71924100 @default.
- W4387253102 hasConcept C74187038 @default.
- W4387253102 hasConcept C86803240 @default.
- W4387253102 hasConcept C98274493 @default.
- W4387253102 hasConceptScore W4387253102C104317684 @default.
- W4387253102 hasConceptScore W4387253102C150903083 @default.
- W4387253102 hasConceptScore W4387253102C185592680 @default.
- W4387253102 hasConceptScore W4387253102C202751555 @default.
- W4387253102 hasConceptScore W4387253102C207001950 @default.
- W4387253102 hasConceptScore W4387253102C26291073 @default.
- W4387253102 hasConceptScore W4387253102C2775905019 @default.
- W4387253102 hasConceptScore W4387253102C2778163477 @default.
- W4387253102 hasConceptScore W4387253102C2779433975 @default.
- W4387253102 hasConceptScore W4387253102C2780035454 @default.
- W4387253102 hasConceptScore W4387253102C55493867 @default.
- W4387253102 hasConceptScore W4387253102C71924100 @default.
- W4387253102 hasConceptScore W4387253102C74187038 @default.
- W4387253102 hasConceptScore W4387253102C86803240 @default.
- W4387253102 hasConceptScore W4387253102C98274493 @default.
- W4387253102 hasIssue "Suppl_1" @default.
- W4387253102 hasLocation W43872531021 @default.
- W4387253102 hasOpenAccess W4387253102 @default.
- W4387253102 hasPrimaryLocation W43872531021 @default.
- W4387253102 hasRelatedWork W2004172311 @default.
- W4387253102 hasRelatedWork W2013765863 @default.
- W4387253102 hasRelatedWork W2084547689 @default.
- W4387253102 hasRelatedWork W2086768837 @default.
- W4387253102 hasRelatedWork W2438771022 @default.
- W4387253102 hasRelatedWork W2463515876 @default.
- W4387253102 hasRelatedWork W2913223560 @default.
- W4387253102 hasRelatedWork W4235616939 @default.
- W4387253102 hasRelatedWork W4308679052 @default.
- W4387253102 hasRelatedWork W4310707532 @default.
- W4387253102 hasVolume "43" @default.
- W4387253102 isParatext "false" @default.
- W4387253102 isRetracted "false" @default.
- W4387253102 workType "article" @default.